Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Erin Larkins"'
Autor:
Katie Chon, Erin Larkins, Somak Chatterjee, Pallavi S. Mishra-Kalyani, Stephanie Aungst, Emily Wearne, Sriram Subramaniam, Yangbing Li, Jiang Liu, Jielin Sun, Rosane Charlab, Hong Zhao, Banu Saritas-Yildirim, Rama Kamesh Bikkavilli, Soma Ghosh, Reena Philip, Julia A. Beaver, Harpreet Singh
Publikováno v:
Clinical Cancer Research. :OF1-OF5
The FDA granted accelerated approval for amivantamab-vmjw (hereafter referred to as amivantamab), a bispecific antibody directed against EGFR and mesenchymal–epithelial transition receptor, on May 21, 2021, for the treatment of adult patients with
Autor:
Luckson N. Mathieu, Erin Larkins, Arup K. Sinha, Pallavi S. Mishra-Kalyani, Samina Jafri, Shyam Kalavar, Soma Ghosh, Kirsten B. Goldberg, Richard Pazdur, Julia A. Beaver, Harpreet Singh
Publikováno v:
Clinical Cancer Research. :OF1-OF6
On October 15, 2021, the FDA approved atezolizumab as adjuvant therapy in patients with stage II to IIIA non–small cell lung cancer (NSCLC) whose tumors have programmed cell death ligand 1 (PD-L1) expression on ≥1% of tumor cells (TC), as detecte
Autor:
Qi Liu, Raina Mathur, Yuan Xu, Aracelis Z. Torres, Rebecca A. Miksad, Chao Liu, Haixia Smithson, Yaning Wang, Hao Zhu, Brian Booth, Shiew‐Mei Huang, Jizu Zhi, Rajeshwari Sridhara, Gideon Michael Blumenthal, Erin Larkins, Pallavi S. Mishra‐Kalyani, Donna R. Rivera, Paul G. Kluetz, Elad Sharon
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:1139-1149
Autor:
Qi Liu, Chenan Zhang, Yue Huang, Ruihao Huang, Shiew-Mei Huang, Erin Larkins, Liza Stapleford, Donna R. Rivera, Paul G. Kluetz, Shenggang Wang, Hao Zhu, James Weese, Elizabeth Cromartie, Mahder Teka, Sheetal Walters, Frank Wolf, Thomas D. Brown
Publikováno v:
Cancer Research Communications. 3:258-266
Pneumonitis is a potentially life-threatening complication of anticancer therapy, and future treatment decisions may be informed by characterizing patients receiving therapies in the real-world setting. In this study, the incidence of treatment-assoc
Autor:
Elizabeth S. Duke, Diana Bradford, Michelle Marcovitz, Anup K. Amatya, Pallavi S. Mishra-Kalyani, Emily Nguyen, Lauren S. L. Price, Jeanne Fourie Zirkelbach, Yangbing Li, Youwei Bi, Jeffrey Kraft, Sarah E. Dorff, Barbara Scepura, Maritsa Stephenson, Idara Ojofeitimi, Abhilasha Nair, Yu Han, Zivana Tezak, Steven J. Lemery, Richard Pazdur, Erin Larkins, Harpreet Singh
Publikováno v:
Clinical Cancer Research.
On September 21, 2022, the U.S. Food and Drug Administration (FDA) granted accelerated approval to selpercatinib (Retevmo®, Eli Lilly and Company) for the treatment of adult patients with locally advanced or metastatic solid tumors with a rearranged
Autor:
Oladimeji Akinboro, Nicole Drezner, Anup Amatya, Jin Runyan, Jeanne Fourie-Zirkelbach, Miao Zhao, Youwei Bi, Kwadwo Korsah, Bronwyn Mixter, Shenghui Tang, Erin Larkins, Richard Pazdur, Julia A. Beaver, Harpreet Singh
Publikováno v:
Journal of Clinical Oncology.
PURPOSE On March 4, 2022, the US Food and Drug Administration (FDA) approved nivolumab plus platinum-doublet chemotherapy for the neoadjuvant treatment of patients with resectable non–small-cell lung cancer (NSCLC). We discuss the FDA's review of t
Autor:
Thomas D. Brown, Frank Wolf, Sheetal Walters, Mahder Teka, Elizabeth Cromartie, James Weese, Hao Zhu, Shenggang Wang, Paul G. Kluetz, Donna R. Rivera, Liza Stapleford, Erin Larkins, Shiew-Mei Huang, Ruihao Huang, Yue Huang, Chenan Zhang, Qi Liu
Pneumonitis is a potentially life-threatening complication of anticancer therapy, and future treatment decisions may be informed by characterizing patients receiving therapies in the real-world setting. In this study, the incidence of treatment-assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a19b0a63e71f89ad6e13f38039da870
https://doi.org/10.1158/2767-9764.c.6551213
https://doi.org/10.1158/2767-9764.c.6551213
Autor:
Thomas D. Brown, Frank Wolf, Sheetal Walters, Mahder Teka, Elizabeth Cromartie, James Weese, Hao Zhu, Shenggang Wang, Paul G. Kluetz, Donna R. Rivera, Liza Stapleford, Erin Larkins, Shiew-Mei Huang, Ruihao Huang, Yue Huang, Chenan Zhang, Qi Liu
Supplementary Table 1. Pneumonitis defined using A) ICD-9 and B) ICD-10 codes that included ‘pneumonitis’ or associated concepts in the Unified Medical Language System, with Bidirectional General Equivalence Mappings used to identify equivalent t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dcacb708652ae3ad5fd0f9f6ccf13bd
https://doi.org/10.1158/2767-9764.22546574
https://doi.org/10.1158/2767-9764.22546574
Autor:
Harpreet Singh, Marc R. Theoret, Richard Pazdur, Julia A. Beaver, Paul G. Kluetz, Shenghui Tang, Autumn Zack-Taylor, Reena Philip, Donna Roscoe, Soma Ghosh, Dun Liang, Francisca Reyes Turcu, Rosane Charlab, Jiang Liu, Yangbing Li, Jeanne Fourie Zirkelbach, Lauren S.L. Price, Whitney S. Helms, Amy M. Skinner, Lisa Rodriguez, Sirisha L. Mushti, Erin Larkins, Diana Bradford
On May 8, 2020, the FDA granted accelerated approval to selpercatinib for (i) adult patients with metastatic RET fusion–positive non–small cell lung cancer (NSCLC), (ii) adult and pediatric patients ≥12 years of age with advanced or metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be7343eb8f94d802c06ee615ed48b00e
https://doi.org/10.1158/1078-0432.c.6531198.v1
https://doi.org/10.1158/1078-0432.c.6531198.v1
Autor:
Harpreet Singh, Julia A. Beaver, Marc R. Theoret, Richard Pazdur, Reena Philip, Soma Ghosh, Dun Liang, Hong Zhao, Jiang Liu, Rosane Charlab, Jielin Sun, Youwei Bi, Amal Ayyoub, Whitney S. Helms, Emily Wearne, Pallavi S. Mishra-Kalyani, Somak Chatterjee, Lee H. Pai-Scherf, Erin Larkins, Diana Bradford, Janice Kim
Supplementary Tables S1-S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e4b5d26de3d7ddf0a7029f07d3d7773
https://doi.org/10.1158/1078-0432.22481316.v1
https://doi.org/10.1158/1078-0432.22481316.v1